EW
Edwards Lifesciences
Data as of 2026-07-21
Company attributes
Price
Interactive 5-year price history chart for EW. Latest close $84.55.
Pillar breakdown
0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)
- QualityProfit margins & asset efficiency61StrongHealth Care median (n=166) 50
- ValuePrice vs fundamentals19PoorHealth Care median (n=166) 52
- GrowthRevenue & earnings trajectory37WeakHealth Care median (n=166) 50
- MomentumRecent price strength56StrongHealth Care median (n=166) 49
- HealthBalance sheet & solvency83ExceptionalHealth Care median (n=166) 57
- ProfitabilityROE, ROA, ROIC71ExceptionalHealth Care median (n=166) 48
- TechnicalTrend & volatility signals19PoorHealth Care median (n=166) 56
- RiskVolatility & drawdown profile50AverageHealth Care median (n=166) 46
Pillars not shown: Sentiment, ML (Phase 5+).
Fair price check
6 different valuation methods each estimate what EWshould be worth, then we compare to today's price.
- P/E multiplesOvervaluedthinks it's expensive — estimates $52.30, about 38% below today
- P/B multiplesOvervaluedthinks it's expensive — estimates $51.60, about 39% below today
- EV/EBITDAOvervaluedthinks it's expensive — estimates $50.86, about 40% below today
- Graham (defensive)Overvaluedthinks it's expensive — estimates $32.44, about 62% below today
- DCF (2-stage)Overvaluedthinks it's expensive — estimates $25.06, about 70% below today
- Residual IncomeOvervaluedthinks it's expensive — estimates $22.87, about 73% below today
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
- Median fair
- $41.65
- Margin of safety(vs fair value)
- < −99%
- Max (ex-outliers)
- $52.30
- Tangible BVPS
- $12.64
Median of all applicable methods (current price $84.55). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.
Supporting dataRaw fundamentals & data-quality provenance behind the scores above
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $48.68B |
| Revenue (TTM) | $6.30B |
| Net income (TTM) | $1.10B |
| Operating cash flow (TTM) | $1.36B |
| CapEx (TTM) | $269.10M |
| Free cash flow (TTM)CFO − CapEx | $1.09B |
| Total assets | $13.32B |
| Total liabilities | $2.99B |
| Stockholders' equity | $10.33B |
| Cash & equivalents | $2.45B |
| Shares outstanding | 575.80M |
| EPS (basic) | $1.90 |
| EPS (diluted) | $1.90 |
| P/E ratio (TTM) | 44.41 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-05-06
- Latest period end
- 2026-04-30
- Filing lag
- 76 days
- Missing metrics
- 2(interest_expense, dividends_paid)
Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.